Filing Details

Accession Number:
0000939767-16-000272
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-11-14 19:34:05
Reporting Period:
2016-11-09
Filing Date:
2016-11-14
Accepted Time:
2016-11-14 19:34:05
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
939767 Exelixis Inc. EXEL Services-Commercial Physical & Biological Research (8731) 043257395
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1387306 Peter Lamb C/O Exelixis, Inc.
210 E. Grand Ave.
South San Francisco CA 94080
Evp, Scientific Strategy & Cso No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-11-09 50,000 $5.04 123,600 No 4 M Direct
Common Stock Acquisiton 2016-11-09 20,000 $5.50 143,600 No 4 M Direct
Common Stock Disposition 2016-11-09 70,000 $13.15 73,600 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Option (right to buy) Disposition 2016-11-09 50,000 $0.00 50,000 $5.04
Common Stock Option (right to buy) Disposition 2016-11-09 20,000 $0.00 20,000 $5.50
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2009-12-16 2018-12-15 No 4 M Direct
55,000 2012-09-28 2018-09-27 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 16,024 Indirect By 401(k)
Footnotes
  1. Includes 16,250 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.
  2. The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 27, 2016.
  3. Represents 16,024 shares of Exelixis, Inc. common stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of November 9, 2016.
  4. The option, representing the right to purchase a total of 50,000 shares of Exelixis, Inc. common stock, became fully exercisable on December 16, 2012.
  5. The option, representing the right to purchase a total of 75,000 shares of Exelixis, Inc. common stock, became fully exercisable on September 28, 2015.